We are live on
!
Find out more
FA
Friess Associates Portfolio holdings
AUM
$59.9M
1-Year Est. Return
3.42%
This Fund
S&P 500
This Quarter
Est. Return
-2.16%
1 Year Est. Return
+3.42%
3 Year Est. Return
+255.77%
5 Year Est. Return
+639.06%
10 Year Est. Return
–
AUM
$187M
AUM Growth
-$68.4M
(-27%)
Cap. Flow
-$45.8M
Cap. Flow
% of AUM
-24.44%
Top 10 Holdings %
Top 10 Hldgs %
29.33%
Holding
127
New
37
Increased
30
Reduced
21
Closed
38
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EGIO
Edgio, Inc. Common Stock
EGIO
|
+$5.1M |
| 2 |
Amphastar Pharmaceuticals
AMPH
|
+$4.38M |
| 3 |
CPRX
Catalyst Pharmaceutical
CPRX
|
+$4.04M |
| 4 |
Adtran
ADTN
|
+$3.99M |
| 5 |
HSII
Heidrick & Struggles
HSII
|
+$3.91M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CryoPort
CYRX
|
+$6.21M |
| 2 |
Alpha and Omega Semiconductor
AOSL
|
+$6.09M |
| 3 |
Silicon Motion
SIMO
|
+$5.73M |
| 4 |
ArcBest
ARCB
|
+$5.47M |
| 5 |
Cavco Industries
CVCO
|
+$4.83M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.87% |
| 2 | Consumer Discretionary | 24.3% |
| 3 | Industrials | 18.55% |
| 4 | Healthcare | 13.91% |
| 5 | Materials | 7.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Stratasys
SSYS
$697M
| $7.45M | 3.97% |
293,246
-20,540
| -7% | -$495K |
|
2
ACM Research
ACMR
$5.83B
| $6.79M | 3.63% |
328,350
+124,266
| +61% | +$3.13M |
|
|
EGIO
3
DELISTED
Edgio, Inc. Common Stock
EGIO
| $6.39M | 3.41% |
+30,616
| New | +$5.1M |
|
|
4
Amphastar Pharmaceuticals
AMPH
$825M
| $5.54M | 2.96% |
+154,415
| New | +$4.38M |
|
|
DSKE
5
DELISTED
Daseke, Inc. Common Stock
DSKE
| $5.51M | 2.94% |
547,345
-41,829
| -7% | -$454K |
|
6
Tecnoglass
TGLS
$2.01B
| $5.3M | 2.83% |
210,014
+19,380
| +10% | +$435K |
|
|
CPRX
7
DELISTED
Catalyst Pharmaceutical
CPRX
| $4.74M | 2.53% |
+571,940
| New | +$4.04M |
|
|
TA
8
DELISTED
TravelCenters of America LLC
TA
| $4.57M | 2.44% |
106,457
+9,373
| +10% | +$405K |
|
9
Information Services Group
III
$185M
| $4.53M | 2.42% |
665,455
+60,296
| +10% | +$425K |
|
10
Carriage Services
CSV
$618M
| $4.14M | 2.21% |
77,556
+34,811
| +81% | +$1.84M |
|
|
11
Adtran
ADTN
$798M
| $3.71M | 1.98% |
+201,343
| New | +$3.99M |
|
|
HSII
12
DELISTED
Heidrick & Struggles
HSII
| $3.66M | 1.95% |
+92,527
| New | +$3.91M |
|
13
MarineMax
HZO
$800M
| $3.47M | 1.85% |
86,248
+7,665
| +10% | +$360K |
|
|
ASRT
14
DELISTED
Assertio
ASRT
| $3.43M | 1.83% |
79,763
+21,096
| +36% | +$787K |
|
15
Axogen
AXGN
$2.1B
| $3.35M | 1.79% |
421,651
+162,573
| +63% | +$1.4M |
|
16
DHI Group
DHX
$166M
| $3.19M | 1.7% |
536,484
+116,010
| +28% | +$665K |
|
17
Kura Sushi USA
KRUS
$537M
| $3.16M | 1.68% |
57,237
+17,900
| +46% | +$924K |
|
18
Fabrinet
FN
$17.1B
| $2.95M | 1.57% |
+28,049
| New | +$2.96M |
|
19
HUB Group
HUBG
$3.01B
| $2.94M | 1.57% |
76,034
-40,478
| -35% | -$1.62M |
|
20
Enpro
NPO
$7.05B
| $2.9M | 1.54% |
29,621
-10,800
| -27% | -$1.15M |
|
21
Identive
INVE
$64.6M
| $2.87M | 1.53% |
177,257
-87,474
| -33% | -$1.68M |
|
|
NVEE
22
DELISTED
NV5 Global
NVEE
| $2.86M | 1.53% |
85,828
-61,720
| -42% | -$1.81M |
|
23
Academy Sports + Outdoors
ASO
$2.89B
| $2.77M | 1.48% |
70,258
-51,260
| -42% | -$1.88M |
|
|
ARIS
24
DELISTED
Aris Water Solutions
ARIS
| $2.69M | 1.44% |
+147,865
| New | +$2.14M |
|
|
LAC
25
DELISTED
Lithium Americas Corp. Common Shares
LAC
| $2.65M | 1.41% |
+68,795
| New | +$1.96M |
|
Similar funds
CRCM
BAM
PL
KIP
LCM
IRF
HIH
SM
Friess Associates's Q1 2022 Portfolio in Review
As of Q1 2022, Friess Associates held 127 positions worth $187M, down 27% from $256M the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Friess Associates withdrew a net $45.8M in Q1 2022, closing 38 positions and reducing 21 holdings. Its most notable exit was CryoPort, an estimated $6.21M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Consumer Discretionary and Industrials.
Against the trend, Friess Associates opened a new position in Edgio, Inc. Common Stock worth $6.39M.
- Friess Associates's largest Q1 2022 buy was Edgio, Inc. Common Stock: 30,616 shares worth $6.39M.
- Friess Associates added most to ACM Research in Q1 2022, an estimated $3.13M increase.
- Friess Associates's biggest Q1 2022 reduction was Titan Machinery, cutting an estimated $4.11M.
- Friess Associates fully exited CryoPort in Q1 2022, selling an estimated $6.21M.
- Friess Associates's ten largest holdings make up 29% of its $187M portfolio in Q1 2022.
- Friess Associates opened 37 new positions and closed 38 in Q1 2022.
- Friess Associates's portfolio value fell 27% quarter-over-quarter to $187M.
Based on Friess Associates's 13F filing for Q1 2022, filed 12 May 2022.